Medicare Compliance & Reimbursement

INDUSTRY NOTES:

Medicare Reimbursement Changes Increase Bladder Cancer Treatment Costs

The changes are well-intentioned, but experts can't explain why they're not working. The startling conclusion of a study published online this Feb. 8 in Cancer -- a peer-reviewed journal of the American Cancer Society -- indicates that increased Medicare payments to physicians for outpatient surgeries for bladder cancer might have led to a steep rise in the number of procedures performed. This resulted in Medicare expenditure for outpatient bladder surgery procedures growing by almost twofold, a rise which could not be explained by the increase in the number of bladder cancer referrals during the corresponding period alone or the degree to which cancer was treated definitively in the office, noted the authors of the study. The authors of the study compared Medicare reimbursements during 2002-2004 (Period 1) with reimbursements during 2005-2007 (Period 2) and found a 1.76-fold increase in Period 2 compared to Period 1. "Our study was not intended to be [...]
You’ve reached your limit of free articles. Already a subscriber? Log in.
Not a subscriber? Subscribe today to continue reading this article. Plus, you’ll get:
  • Simple explanations of current healthcare regulations and payer programs
  • Real-world reporting scenarios solved by our expert coders
  • Industry news, such as MAC and RAC activities, the OIG Work Plan, and CERT reports
  • Instant access to every article ever published in your eNewsletter
  • 6 annual AAPC-approved CEUs*
  • The latest updates for CPT®, ICD-10-CM, HCPCS Level II, NCCI edits, modifiers, compliance, technology, practice management, and more
*CEUs available with select eNewsletters.

Other Articles in this issue of

Medicare Compliance & Reimbursement

View All